Informations bibliographiques
Ligne directriceWHO updated recommendations on HIV clinical management: recommendations for a public health approach
Année de publication2025
Institution émettriceWorld Health Organization
Recommandation
Nouvelle
Use of long-acting injectable antiretroviral regimens in HIV treatment. Long-acting injectable cabotegravir + rilpivirine (CAB+RPV) can be used as an alternative switching option in adults and adolescents who have an undetectable HIV viral load on oral ART and no active hepatitis B infection.
Recommandé en faveur
Conditionnelle
Certitude des données probantes
Modérée